Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.35M Buy
23,056
+3,756
+19% +$1.29M 0.09% 185
2026
Q1
$6.79M Buy
19,300
+823
+4% +$293K 0.08% 192
2025
Q4
$6.05M Buy
18,477
+5,382
+41% +$1.71M 0.08% 189
2025
Q3
$3.7M Sell
13,095
-1,399
-10% -$406K 0.05% 247
2025
Q2
$4.05M Buy
14,494
+4,456
+44% +$1.26M 0.06% 193
2025
Q1
$3.13M Buy
10,038
+4,082
+69% +$1.21M 0.05% 181
2024
Q4
$1.55M Sell
5,956
-1,017
-15% -$302K 0.03% 206
2024
Q3
$2.25M Buy
6,973
+199
+3% +$65.1K 0.04% 128
2024
Q2
$2.12M Sell
6,774
-143
-2% -$42K 0.05% 117
2024
Q1
$1.97M Buy
6,917
+4,187
+153% +$1.23M 0.05% 119
2023
Q4
$786K Buy
2,730
+420
+18% +$114K 0.03% 115
2023
Q3
$621K Buy
2,310
+1,092
+90% +$273K 0.03% 113
2023
Q2
$270K Buy
+1,218
New +$283K 0.03% 114

Other funds holding AMGN

Vest Financial's AMGN Position: Q2 2026 in Review

Vest Financial increased its Amgen (AMGN) stake by 19% in Q2 2026, buying an estimated $1.29M and bringing the position to 23,056 shares worth $8.35M. The position accounts for 0.09% of the portfolio, ranked #185.

Vest Financial first reported a position in AMGN in Q2 2023 and has held it in 13 quarters since. 1,264 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Vest Financial held 23,056 shares of Amgen worth $8.35M as of Q2 2026.
  • Vest Financial bought 3,756 Amgen shares in Q2 2026, an estimated $1.29M.
  • Amgen made up 0.09% of Vest Financial's portfolio in Q2 2026, its #185 holding.
  • Vest Financial first reported a position in Amgen in Q2 2023 and has held it in 13 quarters since.
  • 1,264 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Vest Financial's 13F filing for Q2 2026, filed 24 Jul 2026.